IDSA GUIDELINES Bundle (free trial)

Diagnosis of TB Guidelines PDF

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/847015

Contents of this Issue

Navigation

Page 7 of 11

8 Diagnosis ➤ The panel recommends performing rapid molecular drug susceptibility testing for rifampin with or without isoniazid using the respiratory specimens of persons who are either AFB smear positive or Hologic Amplified MTD positive and who meet one of the following criteria (S-M): • have been treated for tuberculosis in the past • were born in or have lived for ≥1 year in a foreign country with at least a moderate tuberculosis incidence (≥20 per 100,000) or a high primary multidrug-resistant tuberculosis prevalence (≥2%) • are contacts of patients with multidrug-resistant tuberculosis, or • are HIV infected. Remarks: This recommendation specifically addresses patients who are Hologic Amplified MTD positive because the Hologic Amplified MTD NAAT only detects TB and not drug resistance. It is not applicable to patients who are positive for types of NAAT that detect drug resistance, including many line probe assays and Cepheid Xpert MTB/RIF. ➤ The panel suggests mycobacterial culture of respiratory specimens for all children suspected of having pulmonary TB (C-M). Remarks: In a low incidence setting like the United States, it is unlikely that a child identified during a recent contact investigation of a close adult/adolescent contact with contagious TB was, in fact, infected by a different individual with a strain with a different susceptibility pattern. Therefore, under some circumstances, microbiological confirmation may not be necessary for children with uncomplicated pulmonary TB identified through a recent contact investigation if the source case has drug-susceptible TB. ➤ The panel suggests sputum induction rather than flexible bronchoscopic sampling as the initial respiratory sampling method for adults with suspected pulmonary TB who are either unable to expectorate sputum or whose expectorated sputum is AFB smear microscopy negative (C-L). ➤ The panel suggests flexible bronchoscopic sampling, rather than no bronchoscopic sampling, in adults with suspected pulmonary TB from whom a respiratory sample cannot be obtained via induced sputum (C-VL). Remarks: In the committee members' clinical practices, bronchoalveolar lavage (BAL) plus brushings alone are performed for most patients. However, for patients in whom a rapid diagnosis is essential, transbronchial biopsy is also performed. ➤ The panel suggests that postbronchoscopy sputum specimens be collected from all adults with suspected pulmonary TB who undergo bronchoscopy (C-L). Remarks: Postbronchoscopy sputum specimens are used to perform AFB smear microscopy and mycobacterial cultures.

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Diagnosis of TB Guidelines PDF